Back to Search
Start Over
Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis - Authors' reply.
- Source :
-
The Lancet. Rheumatology [Lancet Rheumatol] 2023 Jun; Vol. 5 (6), pp. e313. - Publication Year :
- 2023
-
Abstract
- Competing Interests: MP receives research funding from AbbVie and AstraZeneca and consulting fees from Novartis. JL received a research grant from Pfizer. KG receives consulting fees from AbbVie, Almiral, Amgen, Bristol Myers Squibb, Dermavant, Dermira, Eli Lilly, Janssen, Kyowa Hakko Kirin, Leo, Novartis, Pfizer, Sun, UCB, and Union; payment or honoraria for speakers bureaus from Bristol Myers Squibb; and payment or honoraria for manuscript writing support from UCB, Bristol Myers Squibb, and Janssen. SS declares no competing interests.
Details
- Language :
- English
- ISSN :
- 2665-9913
- Volume :
- 5
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- The Lancet. Rheumatology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 38251598
- Full Text :
- https://doi.org/10.1016/S2665-9913(23)00124-8